Journal article
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial
Abstract
ObjectivesSome patients with rheumatoid arthritis develop interstitial lung disease (RA-ILD) that develops into progressive pulmonary fibrosis. We assessed the efficacy and safety of nintedanib versus placebo in patients with progressive RA-ILD in the INBUILD trial.MethodsThe INBUILD trial enrolled patients with fibrosing ILD (reticular abnormality with traction bronchiectasis, with or without honeycombing) on high-resolution computed …
Authors
Matteson EL; Aringer M; Burmester GR; Mueller H; Moros L; Kolb M
Journal
Clinical Rheumatology, Vol. 42, No. 9, pp. 2311–2319
Publisher
Springer Nature
Publication Date
September 2023
DOI
10.1007/s10067-023-06623-7
ISSN
0770-3198